Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy (vol 31, S472, 2020)
- Authors
- Liu, SV[Liu, S. V.]; De Braud, F[De Braud, F.]; Drilon, A[Drilon, A.]; Doebele, RC[Doebele, R. C.]; Patel, MR[Patel, M. R.]; Cho, BC[Cho, B. C.]; Ahn, MJ[Ahn, M. J.]; Chiu, CH[Chiu, C. H.]; Farago, AF[Farago, A. F.]; Goto, K[Goto, K.]; Lee, J[Lee, J.]; Ohe, Y[Ohe, Y.]; Ou, SHI[Ou, S. H. I.]; Cassier, P[Cassier, P.]; Tan, DSW[Tan, D. S. W.]; Otterson, GA[Otterson, G. A.]; Veronese, L[Veronese, L.]; Osborne, S[Osborne, S.]; Simmons, B[Simmons, B.]; Siena, S[Siena, S.]
- Issue Date
- Apr-2021
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.32, no.4, pp.577 - 577
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 32
- Number
- 4
- Start Page
- 577
- End Page
- 577
- ISSN
- 0923-7534
- Abstract
- The organisers regret that the table presented in this abstract was incorrect. The correct table is as follows: [Table presented] The organisers would like to apologise for any inconvenience caused. © 2021 European Society for Medical Oncology
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.